pdf attached to the following correspondence: STRATTERA Instances Of Death.pdf
"Open letter to Professor Kent Woods, Chief Executive MHRA
November 04, 2007
The MHRA’s failure to ACT to protect children from being harmed by the ADHD drug Strattera - part II
In the end of July I gave data about Strattera to the MHRA and asked:
What will need to happen for the MHRA to withdraw this destructive drug from the market? Or what will need to happen for the agency to do something effective to protect children from being harmed by the drug?
I got no answer.
The data in this letter is an addition to the letter from July. The questions are even more valid today. Especially as some incredible data now have emerged: Data from FDA say that 52 persons died in connection with Strattera treatment 2004-2006. AND: 29 of these persons were children and adolescents below the age of 18.
I suppose the MHRA is in possession of these data already, but to be sure I attach them to this letter. The 29 children are marked with red in the report (compiled by me from published data). Of course the 29 children reported to the FDA are only a part of all the children killed by the drug.
As the number of instances of death is much higher than 29 children I want to end off whith this question: How many children below the age of 18 have died in connection with Strattera treatment since the drug was approved in 2002?
Yours sincerely,
Janne Larsson
Reporter – investigating psychiatry
Sweden
(email address) "
